Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.64 |
| ▸ | MGAM | O43451 | 1/20 | 0.64 |
| ▸ | SI | P14410 | 1/20 | 0.64 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28825664 | 0.98 | GAA (0.61) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL28048928 | 0.98 | GAA (0.61) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL28048908 | 0.98 | GAA (0.61) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL28048925 | 0.98 | GAA (0.61) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL24023251 | 0.89 | GAA (0.56) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL9290670 | 0.84 | GAA (0.61) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL6222514 | 0.84 | GAA (0.45) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL17720258 | 0.82 | GAA (0.58) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL10185937 | 0.82 | GAA (0.58) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL17117349 | 0.82 | GAA (0.58) | GAAMGAMSIMGAM2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1744 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117466938-A | Luminescent material, ink composition and display panel | 广州华星光电半导体显示技术有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-113652407-B | Carbonyl reductase mutant and application thereof in asymmetric synthesis of chiral compound | 浙江工业大学 | 2024-01-16 | — | — | CN | claimed |
| CN-117019131-A | Preparation method of Mg-Sr-K supported catalyst and application of catalyst in preparation of bio-based film-forming auxiliary isobutyryl ethyl acetate by ethyl acetate dehydrogenation | 润泰化学（泰兴）有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-115555034-B | Composite catalyst for converting carbonyl into methylene and preparation method for efficiently catalyzing synthesis of cholesterol by composite catalyst | 湖南科瑞生物制药股份有限公司 | 2023-08-18 | — | — | CN | claimed |
| CN-116199623-A | Preparation method of key intermediate of sorafenib | 浙江科聚生物医药有限公司 | 2023-06-02 | — | — | CN | claimed |
| US-20230167310-A1 | CURING CATALYST AND RESIN COMPOSITION | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2023-06-01 | — | — | US | claimed |
| EP-4144436-A1 | CURING CATALYST AND RESIN COMPOSITION | Koei Chemical Company, Limited (JP) | 2023-03-08 | — | — | EP | claimed |
| CN-115555034-A | Composite catalyst for converting carbonyl into methylene and preparation method for efficiently catalyzing cholesterol synthesis by using composite catalyst | 湖南科瑞生物制药股份有限公司 | 2023-01-03 | — | — | CN | claimed |
| CN-115461147-A | Curing catalyst and resin composition | 广荣化学株式会社 | 2022-12-09 | — | — | CN | claimed |
| CN-112899246-B | Aldehyde ketone reductase KmAKR mutant and application thereof in catalytic synthesis of chiral alcohol | 浙江工业大学 | 2022-06-21 | — | — | CN | claimed |
| CN-112778133-A | high-pH-value chrome tanning auxiliary agent containing polyfunctional group structure and preparation method and application thereof | 南京工业大学 | 2021-05-11 | — | — | CN | claimed |
| CN-112358396-A | Preparation process of ethyl isobutyrylacetate | 门希国 | 2021-02-12 | — | — | CN | claimed |
| CN-107686475-B | Synthesis method of 2,3, 5-trisubstituted thiophene and derivatives thereof | 湘潭大学 | 2020-09-25 | — | — | CN | claimed |
| CN-108084111-B | Method for synthesizing amine compound containing sulfur and nitrogen heterocycles as drug intermediate | 烟台宁远药业有限公司 | 2020-09-04 | — | — | CN | claimed |
| US-20190315892-A1 | POLYMERS INCLUDING A METHYLENE BETA-KETOESTER AND PRODUCTS FORMED THEREFROM | SIRRUS, INC. | 2019-10-17 | — | — | US | claimed |
| US-20170355789-A1 | POLYMERS INCLUDING A METHYLENE BETA-KETOESTER AND PRODUCTS FORMED THEREFROM | SIRRUS, INC. | 2017-12-14 | — | — | US | claimed |
| US-20170073438-A1 | POLYMERS INCLUDING A METHYLENE BETA-KETOESTER AND PRODUCTS FORMED THEREFROM | SIRRUS, INC. | 2017-03-16 | — | — | US | claimed |
| EP-2768872-A1 | METHYLENE BETA-KETOESTER MONOMERS, METHODS FOR MAKING METHYLENE BETA-KETOESTER MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM | Bioformix LLC (US) | 2014-08-27 | — | — | EP | claimed |
| WO-2013066629-A1 | METHYLENE BETA-KETOESTER MONOMERS, METHODS FOR MAKING METHYLENE BETA-KETOESTER MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM | BIOFORMIX, LLC (US) | 2013-05-10 | — | — | WO | claimed |
| US-5637449-A | EMULSION LAYER CONSISTS OF A PHOTOSENSITIVE SILVER HALIDE, A NON-PHOTOSENSITIVE, REDUCIBLE SILVER SOURCE, A REDUCING AGENT SYSTEM CONTAINING HINDERED PHENOL, CO-DEVELOPER, HYDROGEN ATOM DONER COMPOUND, AND A BINDER | IMATION CORP (US) | 1997-06-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170355789-A1 | POLYMERS INCLUDING A METHYLENE BETA-KETOESTER AND PRODUCTS FORMED THEREFROM | BHMT2, BHMT, MACF1 | GAA 2023/4885MGAM 64/4885SI 890/4885 |
| US-20190315892-A1 | POLYMERS INCLUDING A METHYLENE BETA-KETOESTER AND PRODUCTS FORMED THEREFROM | BHMT2, MACF1, BHMT | GAA 2252/4885MGAM 89/4885SI 1281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.